PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Thousand Oaks Surgeon Offers Non-Surgical Facelift With JUVEDERM VOLUMA XC

Dr. Kouros Azar provides injections of the dermal filler JUVEDERM VOLUMA XC to patients at his Thousand Oaks plastic surgery practice, where he was one of the first plastic surgeons in the U.S. to use the breakthrough cheek volumizer.

Thousand Oaks Surgeon Offers Non-Surgical Facelift With JUVEDERM VOLUMA XC
2014-03-30
THOUSAND OAKS, CA, March 30, 2014 (Press-News.org) Renowned plastic surgeon Dr. Kouros Azar (www.azarplasticsurgery.com) is the leading injector of JUVEDERM VOLUMA XC in Thousand Oaks, where his plastic surgery practice offers the new dermal filler as an anti-aging option that doesn't require surgery.

Dr. Azar was one of only 2 plastic surgeons in Southern California to receive VOLUMA XC before anyone else after it was approved by the FDA in fall 2013, and he is now one of a handful of surgeons in the region who trains other doctors in the use of the product. More patients get VOLUMA XC injections at the plastic surgeon's Thousand Oaks practice than anywhere else in the area.

"I'm proud to be one of the first surgeons in the country to offer this breakthrough product and to be the top VOLUMA injector in the region," Dr. Azar says.

VOLUMA XC is an injectable gel and the only filler approved by the FDA to restore volume to the mid-face area, including the cheeks. Plastic surgeons consider it a milestone product because it lasts a long time and effectively mimics some of the results of a facelift. In Thousand Oaks, Dr. Azar says, many of his patients desire a more youthful appearance but aren't ready for plastic surgery.

"Plastic surgeons have known for a long time that the key to an effective facelift is not simply stretching the skin tighter, but also lifting and rearranging the fat in the mid-face," Dr. Azar says. "VOLUMA XC restores volume in the cheeks that is lost as people age. It can delay, or even eliminate, the need for a facelift in some patients, and it's more affordable than surgery."

The key ingredient of VOLUMA XC, like many other popular facial fillers, is hyaluronic acid, a substance that is found naturally in the body. That means allergic reactions are extremely rare and the cosmetic results look very natural.

"One of the most attractive features of VOLUMA XC is that it's been clinically tested to last up to 2 years," Dr. Azar says. "Most other fillers don't last that long."

Dr. Azar adds that many patients get a complete facial rejuvenation when combining VOLUMA XC with other injectables, such as BOTOX Cosmetic and other dermal fillers at his Ventura County office.

"The results are truly remarkable," he says. "You can target different areas with these different products and make your face look years younger, and you don't have the downtime or expense of surgery. VOLUMA XC is a big step forward for these non-surgical treatments."

Dr. Kouros Azar (www.azarplasticsurgery.com) is a board-certified plastic surgeon serving Thousand Oaks, Simi Valley, Agoura Hills, and Westlake Village. After earning his medical degree from Case Western Reserve University, Dr. Azar completed a general surgery residency at University of Arizona and a fellowship in plastic and reconstructive surgery at the University of Utah. He is a member of The American Society for Aesthetic Plastic Surgery and the American Society of Plastic Surgeons. He performs a variety of reconstructive and cosmetic surgical techniques for the face, breasts, and body, and he offers a wide range of non-surgical aesthetic treatments.

[Attachments] See images for this press release:
Thousand Oaks Surgeon Offers Non-Surgical Facelift With JUVEDERM VOLUMA XC

ELSE PRESS RELEASES FROM THIS DATE:

Risk Management Executive, James Hice, Named Risk Manager and General Counsel at McCusker & Company

Risk Management Executive, James Hice, Named Risk Manager and General Counsel at McCusker & Company
2014-03-30
Risk Management executive, and highly-regarded industry insider, James Hice, was today named Risk Manager and General Counsel at McCusker & Company, a leading international provider of warranty protection solutions for the commercial and consumer electronics industry. "I am pleased to name James Hice our new Risk Manager and General Counsel," said McCusker & Company Chief Executive Officer Will L. McCusker. "His connections, insight, expertise and industry knowledge will be invaluable for our company." Hice was the Vice President of Operations and Procurement ...

Envision Built Offers Custom Built Transformations of Screened Porches and Patios into Spacious Three Season Sunrooms to Extend Living Spaces in Cary, Durham and the Greater Raleigh NC Area

2014-03-30
Envision Built Home Remodeling is a custom home renovation specialist - transform your screened porch or patio into a three seasons sunroom, extending the living space of your home. Envision Built is an award-winning remodeling designer and builder. "A fairly easy way to extend the living space in your home is convert your screened porch or patio into a beautiful sunroom," said Bill Ahle, Owner of Envision Built. "Every major renovation begins with a five hour design session working with our interior designer to help you develop a plan, select color schemes and to map ...

SchureMed to Unveil Schure Loc XPS Medical Device at AORN in Chicago

SchureMed to Unveil Schure Loc XPS Medical Device at AORN in Chicago
2014-03-30
SchureMed announced today plans to present their newest and most innovative surgical positioning device at the AORN Show at McCormick Place in Chicago IL. The Schure Loc XPS Extremity Positioning System advances surgical patient positioning by combining both absolute rigid fixation of the patient's limb with unlimited range of motion both pre- and intra-operatively during shoulder arthroscopy, rotator cuff and total shoulder replacement procedures. Unlike other devices that use bulky hydraulic systems and supplementary power units, the Schure Loc XPS employs an ingenious ...

Texas Based Modern Intellects Artist Gift Releases The Trip EP

Texas Based Modern Intellects Artist Gift Releases The Trip EP
2014-03-29
The release of Gift's EP "The Trip" has been eagerly awaited by fans since mid-2013, the uniquely creative video countdown gave fans but a glimpse inside the mind of the independent rapper and the creative process of the project, leaving listeners and viewers wanting more. Gift first began writing at 16 years old after a serious hamstring injury that ended his future in track and field, but ended up being what would pave the way for his future. Fans have the choice of downloading the EP for free or making a donation by visiting www.giftrapsmusic.com or the artist's SoundCloud ...

Relaxed blood pressure guidelines cut millions from needing medication

2014-03-29
DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers. The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90. Blood pressure goals were also eased for adults with diabetes and kidney ...

Study estimates proportion of adults affected by new blood pressure guideline

2014-03-29
Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. Ann Marie Navar-Boggan, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues quantified the proportion of adults potentially ...

US, European cholesterol guidelines differ in statin use recommendations

2014-03-29
Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle ...

Analysis supports use of risk equations to guide statin therapy

2014-03-29
In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published ...

Celiac disease linked to increased risk of coronary artery disease

2014-03-29
People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. The study is the first to look at the association between celiac disease and coronary artery disease and adds to the evolving understanding of how systemic inflammation and autoimmune processes might influence cardiovascular disease development. Data also showed a slightly higher risk of stroke among people with celiac disease compared ...

Are statins good for your love life?

2014-03-29
Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors where cholesterol-lowering statins are frequently prescribed. Previous research has suggested a negative association between statin therapy and testosterone levels, leading to ...

LAST 30 PRESS RELEASES:

Interpreting population mean treatment effects in the Kansas City Cardiomyopathy Questionnaire

Targeting carbohydrate metabolism in colorectal cancer: Synergy of therapies

Stress makes mice’s memories less specific

Research finds no significant negative impact of repealing a Depression-era law allowing companies to pay workers with disabilities below minimum wage

Resilience index needed to keep us within planet’s ‘safe operating space’

How stress is fundamentally changing our memories

Time in nature benefits children with mental health difficulties: study

In vitro model enables study of age-specific responses to COVID mRNA vaccines

Sitting too long can harm heart health, even for active people

International cancer organizations present collaborative work during oncology event in China

One or many? Exploring the population groups of the largest animal on Earth

ETRI-F&U Credit Information Co., Ltd., opens a new path for AI-based professional consultation

New evidence links gut microbiome to chronic disease outcomes

Family Heart Foundation appoints Dr. Seth Baum as Chairman of the Board of Directors

New route to ‘quantum spin liquid’ materials discovered for first time

Chang’e-6 basalts offer insights on lunar farside volcanism

Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source

Zinc deficiency promotes Acinetobacter lung infection: study

How optogenetics can put the brakes on epilepsy seizures

Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds

Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants

Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

[Press-News.org] Thousand Oaks Surgeon Offers Non-Surgical Facelift With JUVEDERM VOLUMA XC
Dr. Kouros Azar provides injections of the dermal filler JUVEDERM VOLUMA XC to patients at his Thousand Oaks plastic surgery practice, where he was one of the first plastic surgeons in the U.S. to use the breakthrough cheek volumizer.